CLOs on the Move

Fister Lauberth

www.fisterlauberth.com

 
Fister Lauberth is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Premier Diagnostic Health Services

Premier Diagnostic Health Services Inc. (“Premier”, “PDH” or the “Company”) is a Canadian corporation with its head office in Burnaby, British Columbia. PDH designs, finances, builds and operates free standing diagnostic imaging centres with no outside affiliation in Canada, and joint venture, diagnostic imaging centres in China with local hospitals. PDH specializes in PET/CT and MRI scanning for the detection and evaluation of cancer, heart disease and neurological disorders

Alpha Medical

Your doctor’s office is now online. From primary care to mental health, we’ve got you covered.

Charles T Sitrin Health Care

Charles T Sitrin Health Care is a New Hartford, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Metro Community Provider Network

MCPN provides excellent health-related services focusing on the underserved. MCPN has one of the largest population bases of any community health center in Colorado. MCPN is dedicated to being a positive work place with employees that are committed to being focused and disciplined team members. MCPN is also dedicated to taking care of our patients and our employees to ensure the best quality of life. Career Opportunities ! MCPN is committed to quality growth and is interested in speaking with unique individuals who want more in a career. Currently we are looking for Family Practice Physicians, Physician Assistants, Nurse Practitioners, Dentists, Dental Hygienists, and other Business Professionals. We offer top compensation, world class benefits, flexible hours and a belief in work/life balance. We look forward to hearing from you! Make your career exceptional by joining us.

Parker Institute for Cancer Immunotherapy

For decades, entrenched infrastructure barriers have slowed progress in the fight against cancer and the development of potent immunotherapies. The Parker Institute for Cancer Immunotherapy breaks down these barriers. The result is groundbreaking new research and an intellectual property model that builds collaboration between researchers, nonprofits and industry all working together to get treatments to patients faster.